Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cowan

Showing results (921-930 of 1,002) with videos related to

Pageof 101
Sort By:
Journal of Medicinal Chemistry|May 18, 2013
Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetesYulin Wu, Christopher J Aquino, David J Cowan, et al.
Journal of Clinical Immunology|April 21, 2022
Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene TherapyDanielle E Arnold, Deepak Chellapandian, Suhag Parikh, et al.
Transplantation and Cellular Therapy|April 9, 2023
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Emily C Liang, Qian Vicky Wu, et al.
American Journal of Hematology|April 16, 2024
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFINRebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, et al.
Nature Methods|January 15, 2025
Resolving tissue complexity by multimodal spatial omics modeling with MISOKyle Coleman, Amelia Schroeder, Melanie Loth, et al.
Blood Cancer Journal|July 8, 2024
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFINAjai Chari, Jonathan L Kaufman, Jacob Laubach, et al.
Blood|September 23, 2020
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D Bezerra, Alexandre V Hirayama, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
The New England Journal of Medicine|January 21, 2016
Mutations in TUBB8 and Human Oocyte Meiotic ArrestRuizhi Feng, Qing Sang, Yanping Kuang, et al.
Pageof 101

Showing results (921-930 of 1,002) with videos related to

Sort By:
Pageof 101
Journal of Medicinal Chemistry|May 18, 2013
Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetesYulin Wu, Christopher J Aquino, David J Cowan, et al.
Journal of Clinical Immunology|April 21, 2022
Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene TherapyDanielle E Arnold, Deepak Chellapandian, Suhag Parikh, et al.
Transplantation and Cellular Therapy|April 9, 2023
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell TherapyNicolas Gazeau, Emily C Liang, Qian Vicky Wu, et al.
American Journal of Hematology|April 16, 2024
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFINRebecca Silbermann, Jacob Laubach, Jonathan L Kaufman, et al.
Nature Methods|January 15, 2025
Resolving tissue complexity by multimodal spatial omics modeling with MISOKyle Coleman, Amelia Schroeder, Melanie Loth, et al.
Blood Cancer Journal|July 8, 2024
Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFINAjai Chari, Jonathan L Kaufman, Jacob Laubach, et al.
Blood|September 23, 2020
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D Bezerra, Alexandre V Hirayama, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
The New England Journal of Medicine|January 21, 2016
Mutations in TUBB8 and Human Oocyte Meiotic ArrestRuizhi Feng, Qing Sang, Yanping Kuang, et al.
Pageof 101